Back to Browse Journals » Open Access Emergency Medicine » Volume 2

Strategies for the prevention and treatment of sudden cardiac death

Authors Emad F Aziz, Fahad Javed, Balaji Pratap, et al

Published Date December 2010 Volume 2010:2 Pages 99—114

DOI http://dx.doi.org/10.2147/OAEM.S6869

Published 10 December 2010

Emad F Aziz, Fahad Javed, Balaji Pratap, Eyal Herzog
The Advanced Cardiac Admission Program, St Luke's-Roosevelt Hospital Center, University Hospital of Columbia University, College of Physicians and Surgeons, New York, NY, USA

Abstract: Cardiovascular diseases account for 40% of all deaths in the West. Sudden cardiac death (SCD) is a major health problem affecting over 300,000 patients annually in the United States alone. Presence of coronary artery disease (CAD), usually in the setting of diminished left ventricular ejection fraction, is still the single major risk factor for SCD. Additionally, acute myocardial ischemia, structural cardiac defects, anomalous coronary arteries, cardiomyopathies, genetic mutations, and ventricular arrhythmias are all attributed to SCD, demonstrating the perplexity of this condition. With the recent advancements in cardiovascular medicine, the incidence of SCD is expected to increase steeply as the prevalence of CAD and heart failure is uprising in general population. Considering SCD, the major challenge confronting contemporary cardiology, multiple strategies for prevention against SCD have been developed. β-blockers have been shown to reduce the risk of SCD, whereas implantable cardioverter–defibrillator devices are found to be effective at terminating the malignant arrhythmias. In recent years, multiple clinical trials were carried out to identify patients who may benefit from preventive intervention, including medical therapy and automatic cardioverter–defibrillator implantations. This review article provides insight into the advanced strategies for the prevention and treatment of SCD based on the data available in medical literature to date.

Keywords: risk stratification, sudden cardiac death, prevention, treatment

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The utility of bexarotene in mycosis fungoides and Sézary syndrome

Panchal MR, Scarisbrick JJ

OncoTargets and Therapy 2015, 8:367-373

Published Date: 3 February 2015

The effect of dietary and/or cosmetic argan oil on postmenopausal skin elasticity

Qiraouani Boucetta K, Charrouf Z, Aguenaou H, Derouiche A, Bensouda Y

Clinical Interventions in Aging 2015, 10:339-349

Published Date: 30 January 2015

Leading teams during simulated pediatric emergencies: a pilot study

Coolen EH, Draaisma JM, den Hamer S, Loeffen JL

Advances in Medical Education and Practice 2015, 6:19-26

Published Date: 6 January 2015

Spirituality in childhood cancer care

Lima NN, do Nascimento VB, de Carvalho SM, Neto ML, Moreira MM, Brasil AQ, Celestino Junior FT, de Oliveira GF, Reis AO

Neuropsychiatric Disease and Treatment 2013, 9:1539-1544

Published Date: 9 October 2013

Critical care in the ED: potentially fatal asthma and acute lung injury syndrome

Hodder R

Open Access Emergency Medicine 2012, 4:53-68

Published Date: 31 August 2012

A case of lethal soft tissue injuries due to assault

Yanagawa Y, Kanawaku Y, Kanetake J

Open Access Emergency Medicine 2012, 4:17-19

Published Date: 28 May 2012